Philadelphia employee benefits health fund accuses Merck, Glenmark of delaying generic Zetia
MLex Summary: Law Enforcement Health Benefits has filed a complaint accusing Merck and Glenmark of entering into an illegal pay-for-delay agreement that kept a generic version of the cholesterol drug Zetia out...To view the full article, register now.
Already a subscriber? Click here to view full article